Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.8%

1 terminated out of 21 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (6)
P 1 (1)
P 2 (3)
P 3 (2)
P 4 (1)

Trial Status

Completed14
Unknown3
Recruiting2
Not Yet Recruiting1
Terminated1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06261827Not ApplicableCompletedPrimary

High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB

NCT04223752Phase 1CompletedPrimary

Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)

NCT06170372Not ApplicableRecruitingPrimary

High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia

NCT06310941Not ApplicableNot Yet Recruiting

Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection

NCT06691399Not ApplicableRecruitingPrimary

Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients

NCT06162455Not ApplicableCompletedPrimary

High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB

NCT01431326Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

NCT05928208CompletedPrimary

The Role of Point-of-care Polymerase Chain Reaction in Managing Nosocomial Pneumonia

NCT04488510Unknown

Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:

NCT02793141CompletedPrimary

International Study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE)

NCT04279873CompletedPrimary

Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia

NCT02598609Not ApplicableCompleted

SEPREVEN: a Stepped-wedge Randomised Controlled Trial

NCT02413242Completed

Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU

NCT03303937CompletedPrimary

Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients

NCT01897792Phase 2Terminated

Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma

NCT01796717Phase 2UnknownPrimary

Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia

NCT01363271Completed

Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients

NCT00236834Phase 3CompletedPrimary

A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

NCT00842478Phase 2Unknown

Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia

NCT00829842Phase 3Completed

Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery

Scroll to load more

Research Network

Activity Timeline